{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:52:00Z","timestamp":1786546320111,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.14309\/crj.2016.45","type":"journal-article","created":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T12:43:39Z","timestamp":1461242619000},"page":"187-189","source":"Crossref","is-referenced-by-count":8,"title":["Chronic Inflammatory Demyelinating Polyneuropathy Following Anti-TNF-\u03b1 Therapy With Infliximab for Crohn's Disease"],"prefix":"10.14309","volume":"3","author":[{"given":"Amir Y.","family":"Kamel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orestes","family":"Concepcion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Schlachterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Glover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher Y.","family":"Forsmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"15","key":"R1-72-20210317","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","article-title":"A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohns disease. Crohns Disease cA2 study group.","volume":"337","author":"Targan","year":"1997","journal-title":"N Engl J Med"},{"issue":"3","key":"R2-72-20210317","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/mus.20924","article-title":"Tumor necrosis factor-alpha antagonists and neuropathy.","volume":"37","author":"Stubgen","year":"2008","journal-title":"Muscle Nerve"},{"issue":"1","key":"R3-72-20210317","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2003.10.047","article-title":"The safety profile of infliximab in patients with Crohns disease: The Mayo Clinic experience in 500 patients.","volume":"126","author":"Colombel","year":"2004","journal-title":"Gastroenterology"},{"issue":"6","key":"R4-72-20210317","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/00007611-199706000-00005","article-title":"Neurologic and neuropsychiatric complications of Crohns disease.","volume":"90","author":"Elsehety","year":"1997","journal-title":"South Med J"},{"issue":"1","key":"R5-72-20210317","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1085-9489.2006.00061.x","article-title":"Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy.","volume":"11","author":"Hughes","year":"2006","journal-title":"J Peripher Nerv Syst"},{"issue":"9","key":"R6-72-20210317","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrneurol.2011.121","article-title":"Advances in the diagnosis, pathogenesis and treatment of CIDP.","volume":"7","author":"Dalakas","year":"2011","journal-title":"Nat Rev Neurol"},{"issue":"pt 4","key":"R7-72-20210317","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/brain\/awh429","article-title":"Peripheral neuropathy in patients with inflammatory bowel disease.","volume":"128","author":"Gondim","year":"2005","journal-title":"Brain"},{"issue":"8","key":"R8-72-20210317","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archneur.1989.00520440064022","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria.","volume":"46","author":"Barohn","year":"1989","journal-title":"Arch Neurol"},{"issue":"5","key":"R9-72-20210317","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00384-009-0646-x","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy associated with inflammatory bowel diseases: Questioning the autoimmunity hypothesis.","volume":"24","author":"Ariatti","year":"2009","journal-title":"Int J Colorectal Dis"},{"issue":"3-4","key":"R10-72-20210317","first-page":"181","article-title":"Crohn disease and chronic inflammatory demyelinating polyneuropathy: A case report.","volume":"50","author":"Boylu","year":"2010","journal-title":"Electromyogr Clin Neurophysiol"},{"issue":"2","key":"RU12-72-20210317","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/00365529109025034","article-title":"Neurophysiologic studies of patients with Crohns disease on long-term treatment with metronidazole.","volume":"26","author":"Stahlberg","year":"1991","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"RU13-72-20210317","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ibd.20304","article-title":"Peripheral neuropathy and neurological disorders in an unselected Brazilian population-based cohort of IBD patients.","volume":"14","author":"Oliveira","year":"2008","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"R14-72-20210317","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/mus.21584","article-title":"Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-alpha antagonists.","volume":"41","author":"Alshekhlee","year":"2010","journal-title":"Muscle Nerve"},{"issue":"5","key":"R15-72-20210317","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/rheumatology\/kes375","article-title":"Pattern of demyelination occurring during anti-TNF- therapy: A French national survey.","volume":"52","author":"Seror","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"R16-72-20210317","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0923-2494(97)87239-2","article-title":"The role of TNF alpha and related cytokines in the development and function of the autoreactive T-cell repertoire.","volume":"148","author":"Cope","year":"1997","journal-title":"Res Immunol"},{"issue":"4","key":"R17-72-20210317","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1084\/jem.193.4.427","article-title":"Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination.","volume":"193","author":"Kassiotis","year":"2001","journal-title":"J Exp Med"},{"issue":"9","key":"R18-72-20210317","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1084\/jem.185.9.1573","article-title":"Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling.","volume":"185","author":"Cope","year":"1997","journal-title":"J Exp Med"},{"issue":"4","key":"R19-72-20210317","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1586\/14787210.1.4.597","article-title":"Pathogenesis of Guillain-Barre syndrome.","volume":"1","author":"Tsang","year":"2003","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"5","key":"R20-72-20210317","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/art.21814","article-title":"Guillain-Barre and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy.","volume":"54","author":"Shin","year":"2006","journal-title":"Arthritis Rheum"}],"container-title":["ACG Case Reports Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/02075970-201603000-00072","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:55:13Z","timestamp":1786542913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/02075970-201603000-00072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.14309\/crj.2016.45","relation":{},"ISSN":["2326-3253"],"issn-type":[{"value":"2326-3253","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}